Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Abbott Laboratories

Market Cap 16TCr 14TCr 13TCr 12TCr 22TCr 14,86300Cr 23TCr 1,53900Cr 60TCr 7,33200Cr 59TCr 58TCr 25,50900Cr P/E 2026 *
22.8x
P/E 2027 * 19.5x
Enterprise Value 17TCr 15TCr 14TCr 13TCr 24TCr 15,96900Cr 25TCr 1,65300Cr 64TCr 7,87700Cr 64TCr 62TCr 27,40600Cr EV / Sales 2026 *
3.37x
EV / Sales 2027 * 3.04x
Free-Float
86.73%
Yield 2026 *
2.81%
Yield 2027 * 3%
1 day+7.63%
1 month+1.93%
3 months-24.71%
6 months-30.19%
Current year-30.19%
1 month 74.08
Extreme 74.08
74.44
Current year 72.68
Extreme 72.68
98.39
1 year 72.68
Extreme 72.68
98.39
3 years 72.68
Extreme 72.68
110.91
5 years 72.68
Extreme 72.68
110.91
10 years 72.68
Extreme 72.68
110.91
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
+7.63%0.00% - - 16TCr
-0.62%+2.55%-6.91%-7.90% 10TCr
-0.51%-2.64%+54.91%+56.80% 5.48TCr
+1.20%+2.66%-3.28%+51.51% 5.47TCr
+2.68%+4.35%-13.87%-42.39% 3.97TCr
+2.12%-1.02% - - 2.98TCr
+1.20%-2.08%-20.35%-44.03% 2.66TCr
+1.20%+5.20%+52.87%-6.75% 2.38TCr
-0.46%-1.62%-18.36%-4.42% 2TCr
+1.95%+3.90%-13.53%-2.28% 1.98TCr
Average +1.56%-2.50%+3.93%+0.07% 4.14TCr
Weighted average by Cap. +2.69%-2.21%+4.81%+5.75%

Financials

2026 *2027 *
Net sales 5.03TCr 4.43TCr 4.08TCr 3.82TCr 7.16TCr 4,74000Cr 7.29TCr 49TCr 19TCr 2,33800Cr 19TCr 18TCr 8,13500Cr 5.48TCr 4.82TCr 4.45TCr 4.16TCr 7.8TCr 5,16500Cr 7.94TCr 53TCr 21TCr 2,54800Cr 21TCr 20TCr 8,86400Cr
Net income 701.88Cr 617.94Cr 569.97Cr 533.08Cr 998.8Cr 66TCr 1.02TCr 6.85TCr 2.65TCr 33TCr 2.64TCr 2.58TCr 1,13500Cr 839.23Cr 738.86Cr 681.51Cr 637.4Cr 1.19TCr 79TCr 1.22TCr 8.19TCr 3.17TCr 39TCr 3.15TCr 3.08TCr 1,35800Cr
Net Debt 1.17TCr 1.03TCr 952.27Cr 890.63Cr 1.67TCr 1,10500Cr 1.7TCr 11TCr 4.43TCr 55TCr 4.4TCr 4.31TCr 1,89700Cr 888.3Cr 782.06Cr 721.35Cr 674.66Cr 1.26TCr 84TCr 1.29TCr 8.67TCr 3.36TCr 41TCr 3.34TCr 3.26TCr 1,43700Cr
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
1,15,000
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
90.53USD
Average target price
116.54USD
Spread / Average Target
+28.73%

Quarterly revenue - Rate of surprise